Shyld AI raises $13.4 million seed round to expand active AI systems across US hospitals

Shyld AI, founded by brothers Mohammad and Morteza Noshad, raised a $13.4 million seed round led by Aulis Capital to fund expansion across US health systems. The round is described as one of the largest early-stage rounds in the healthcare AI sector.

The company builds Agentic AI systems (AI agents that take autonomous action) powered by Vertex, a proprietary foundation model that runs on edge devices within hospital rooms rather than relying on cloud infrastructure. In operating rooms, these agents interpret case progression and delay drivers in real time to optimize disinfection timing, identify missing supplies, and reduce surgical bottlenecks.

A Stanford University study published in the American Journal of Infection Control found that Shyld AI's system—which combines AI with UV-C light technology for autonomous disinfection—reduced contamination by more than 93 percent compared to a control room. Healthcare-associated infections contribute to approximately 72,000 hospital deaths annually in the United States, according to CDC data.

With the new capital, Shyld AI will accelerate deployments across US health systems and expand its Active AI capabilities into additional clinical and industrial applications, including regulated cleanroom environments and pharmaceutical manufacturing.